日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cryoglobulin-Associated Retinal Vasculitis: Retrospective Case Series

冷球蛋白相关性视网膜血管炎:回顾性病例系列

Thomas, Claire; Zubair, Talhah; Monteagudo, Luke; Lotfi-Emran, Sahar; Yamanuha, Justin

Chronic antigen in solid tumors drives a distinct program of T cell residence

实体瘤中的慢性抗原驱动着一种独特的T细胞驻留程序。

Noah V Gavil ,Milcah C Scott ,Eyob Weyu ,Olivia C Smith ,Stephen D O'Flanagan ,Sathi Wijeyesinghe ,Sahar Lotfi-Emran ,Stephen L Shiao ,Vaiva Vezys ,David Masopust

Depleting CD103+ resident memory T cells in vivo reveals immunostimulatory functions in oral mucosa

体内清除CD103+驻留记忆T细胞揭示了其在口腔黏膜中的免疫刺激功能

Stolley, J Michael; Scott, Milcah C; Joag, Vineet; Dale, Alexander J; Johnston, Timothy S; Saavedra, Flavia; Gavil, Noah V; Lotfi-Emran, Sahar; Soerens, Andrew G; Weyu, Eyob; Pierson, Mark J; Herzberg, Mark C; Zhang, Nu; Vezys, Vaiva; Masopust, David

Tissue-resident memory T cells trigger rapid exudation and local antibody accumulation

组织驻留记忆T细胞可触发快速渗出和局部抗体积累。

Rosato, Pamela C; Lotfi-Emran, Sahar; Joag, Vineet; Wijeyesinghe, Sathi; Quarnstrom, Clare F; Degefu, Hanna N; Nedellec, Rebecca; Schenkel, Jason M; Beura, Lalit K; Hangartner, Lars; Burton, Dennis R; Masopust, David

Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies

利用来自5项多中心、随机、对照和前瞻性研究的数据,开发与COVID-19患者重症相关的蛋白质组学特征

Castro-Pearson, Sandra; Samorodnitsky, Sarah; Yang, Kaifeng; Lotfi-Emran, Sahar; Ingraham, Nicholas E; Bramante, Carolyn; Jones, Emma K; Greising, Sarah; Yu, Meng; Steffen, Brian T; Svensson, Julia; Åhlberg, Eric; Österberg, Björn; Wacker, David; Guan, Weihua; Puskarich, Michael; Smed-Sörensen, Anna; Lusczek, Elizabeth; Safo, Sandra E; Tignanelli, Christopher J

Developing A Baseline Metabolomic Signature Associated with COVID-19 Severity: Insights from Prospective Trials Encompassing 13 U.S. Centers

构建与 COVID-19 严重程度相关的基线代谢组学特征:来自涵盖美国 13 个中心的前瞻性试验的启示

Yang, Kaifeng; Kang, Zhiyu; Guan, Weihua; Lotfi-Emran, Sahar; Mayer, Zachary J; Guerrero, Candace R; Steffen, Brian T; Puskarich, Michael A; Tignanelli, Christopher J; Lusczek, Elizabeth; Safo, Sandra E

Mathematical model of SARS-CoV-2 immunity predicts Paxlovid rebound

SARS-CoV-2免疫数学模型预测帕克洛维德(Paxlovid)的反弹

van Grootveld, Rebecca; van der Beek, Martha T; Janssen, Nico A F; Ergün, Mehmet; van Dijk, Karin; Bethlehem, Carina; Stads, Susanne; van Paassen, Judith; Heunks, Leo M A; Bouman, Catherine S C; Reijers, Monique H E; Brüggeman, Roger J; van de Veerdonk, Frank L; van Bree, Sjoerd H W; van den Berg, Charlotte H S B; Kuindersma, Marnix; Wauters, Joost; Beishuizen, Albertus; Verweij, Paul E; Schouten, Jeroen A; Samorodnitsky, Sarah; Castro-Pearson, Sandra; Yang, Kaifeng; Lotfi-Emran, Sahar; Ingraham, Nicholas E; Bramante, Carolyn; Geising, Sarah; Jones, Emma K; Wacker, David; Puskarich, Michael; Lusczek, Elizabeth; Safo, Sandra; Tignanelli, Christopher J; Ranard, Benjamin L; Vodovotz, Yoram; Asgari, Shadnaz; Megjhani, Murad; Chow, Carson C; Park, Soojin

mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses

mTOR抑制剂在COVID-19中的应用:对RNA病毒疗效的评论和综述

Karam, Basil S; Morris, Rachel S; Bramante, Carolyn T; Puskarich, Michael; Zolfaghari, Emily J; Lotfi-Emran, Sahar; Ingraham, Nicholas E; Charles, Anthony; Odde, David J; Tignanelli, Christopher J

Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles

描述 COVID-19 的临床表型及其相关合并症和并发症特征

Lusczek, Elizabeth R; Ingraham, Nicholas E; Karam, Basil S; Proper, Jennifer; Siegel, Lianne; Helgeson, Erika S; Lotfi-Emran, Sahar; Zolfaghari, Emily J; Jones, Emma; Usher, Michael G; Chipman, Jeffrey G; Dudley, R Adams; Benson, Bradley; Melton, Genevieve B; Charles, Anthony; Lupei, Monica I; Tignanelli, Christopher J

Immunomodulation in COVID-19

新冠肺炎中的免疫调节

Ingraham, Nicholas E; Lotfi-Emran, Sahar; Thielen, Beth K; Techar, Kristina; Morris, Rachel S; Holtan, Shernan G; Dudley, R Adams; Tignanelli, Christopher J